Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-23-019023)

Filing Details

Accession Number:: 0001209191-23-019023
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-03-15 18:48:35
Reporting Period:: 2023-03-14

Accepted Time:: 2023-03-15 18:48:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1673772	Rapt Therapeutics Inc.	RAPT	Pharmaceutical Preparations (2834)	473313701

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1791244	Wendye Robbins	C/O Rapt Therapeutics, Inc. 561 Eccles Avenue South San Francisco CA 94080		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-03-14	1,500	$18.75	13,900	No	4	P	Direct
Common Stock	Acquisiton	2023-03-14	400	$18.48	14,300	No	4	P	Direct
Common Stock	Acquisiton	2023-03-14	600	$19.95	14,900	No	4	P	Direct
Common Stock	Acquisiton	2023-03-14	2,500	$20.05	6,500	No	4	P	Indirect	By Spouse

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Indirect	By Spouse

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	6,100	Indirect	TRS FBO Trust of Craig and Wendye McGahey

Footnotes

The total number of shares has been adjusted to correct an inadvertent mathematical error in the total number of shares beneficially owned by the Reporting Person in the prior Form 4s.
The Reporting Person no longer has a reportable beneficial interest in 305 shares of the Issuer's common stock owned by her daughter and included in the Reporting Person's prior ownership reports.